Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
Our study aims to assess the efficacy and safety of linaclotide in patients with overlapping
symptoms of both functional dyspepsia (FD) and constipation-predominant irritable bowel
syndrome (IBS-C).